Washington?

Updated Oct 26, 7:00 PM ET

Lobbying spikes · Q3?

No company raised its lobbying spend by half or more in Q3 2026.

Oct 25

Todd Strategy Group · pharmacy

$500K–$1M

John Rose (R) sold

No stock has both member trades in 90 days and a lobbying change in Q3 2026.

Q3 2026 · 4 public companies

Q3 2026 lobbying 1 filer New issue · Health IssuesNew issue · Medicare/Medicaid Filed Oct 25

Q3 spend?$290KQ2 $0

QoQ?n/avs Q2 2026

YoY?n/avs Q3 2025

Agencies?33 ex-officials

HCRHealth IssuesMMMMedicare/MedicaidTRDTrade (domestic/foreign)

No member trades in 90 days Stock page ›

Q3 2026 lobbying 1 filer New firm · Elevate New issue · Defense Filed Oct 24

Q3 spend?$30KQ2 $0

QoQ?n/avs Q2 2026

YoY?n/avs Q3 2025

Agencies?00 ex-officials

DEFDefense

No member trades in 90 days Stock page ›

Q3 2026 lobbying 1 filer New firm · Foxhound New issue · Defense Filed Oct 24

Q3 spend?$20KQ2 $0

QoQ?n/avs Q2 2026

YoY?n/avs Q3 2025

Agencies?00 ex-officials

DEFDefense

No member trades in 90 days Stock page ›

Q3 2026 lobbying 1 filer New firm · Elevate New issue · Budget/AppropriationsNew issue · Defense Filed Oct 24

Q3 spend?$10KQ2 $0

QoQ?n/avs Q2 2026

YoY?n/avs Q3 2025

Agencies?01 ex-official

BUDBudget/AppropriationsDEFDefense

No member trades in 90 days Stock page ›